During the past decade, Lake Macquarie Private Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 3 clinical trials were completed, i.e. on average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 2 clinical trials were completed. i.e. 22.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lake Macquarie Private Hospital" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "AllVascular" with 1 trials sponsored, "Australasian Gastro-Intestinal Trials Group" with 1 trials sponsored and "Biotronik AG" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lake Macquarie Private Hospital" #1 collaborator was "Hoffmann-La Roche" with 2 trials as a collaborator, "ADIR, a Servier Group company" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Institut Curie" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Lake Macquarie Private Hospital" are "Atherosclerosis" (1 trials), "Breast Cancer" (1 trials), "Coronary Artery Disease" (1 trials), "ER-Negative Breast Cancer" (1 trials) and "Glioblastoma Multiforme" (1 trials). Many other conditions were trialed in "Lake Macquarie Private Hospital" in a lesser frequency.

Most popular intervention types in "Lake Macquarie Private Hospital" are "Drug" (9 trials), "Device" (2 trials), "Other" (2 trials), "Biological" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "MEK162" (2 trials), "4-L-[131I]iodo-phenylalanine (131I-IPA)" (1 trials), "Adjuvant nivolumab" (1 trials) and "Atezolizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lake Macquarie Private Hospital" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Lake Macquarie Private Hospital". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 5 completed trials in Lake Macquarie Private Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Lake Macquarie Private Hospital, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".